Hester Biosciences Limited
HESTERBIO
Rank in Stocks
#16409
Hester Biosciences Limited, founded in 1987 and headquartered in Ahmedabad,... Hester Biosciences Limited, founded in 1987 and headquartered in Ahmedabad, India, specializes in the production and commercialization of veterinary vaccines and a comprehensive array of animal health solutions. The company's operations span both domestic and international markets, structured around two primary divisions: Poultry Healthcare and Animal Healthcare. Its extensive range of poultry vaccines targets numerous conditions, including Newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, egg drop syndrome, reovirus infections, Marek's disease, infectious coryza, fowl cholera, mycoplasma gallisepticum, inclusion body hepatitis, and avian encephalomyelitis. For larger animals, Hester Biosciences provides vaccines designed to combat ailments such as Goat Pox, Peste des Petits Ruminants (PPR), Brucellosis, Mastitis, Metritis, various infectious diseases, reproductive disorders, theileriosis, and parasitic infestations. Beyond vaccines, the company's product portfolio encompasses vital feed supplements like toxin binders, trace minerals, enzyme preparations, and bypass fats. It also supplies disinfectants for maintaining farm hygiene and sanitizing equipment, along with water purification solutions. Nutritional support products are offered, including mineral mixtures, fertility boosters, and growth tonics. A significant portion of their offerings consists of herbal preparations, featuring growth promoters, natural alternatives to choline chloride, stress and immunity enhancers, respiratory aids, liver tonics, wound healing agents, uterine and digestive tonics, anti-bloat remedies, ectoparasiticides, and treatments for anti-mastitis and anti-prolapse conditions.
Share Price
$24.89
Last synced: 2026-11-12
Market Cap
$211.73M
Change (1 day)
-0.23%
Change (1 year)
32.43%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Hester Biosciences Limited (HESTERBIO)
Category
Healthcare
EPS for Hester Biosciences Limited (HESTERBIO)
EPS as of September 2026 TTM: $1.78
According to Hester Biosciences Limited's latest financial reports, its current EPS (TTM) is $1.78. At the end of 2025 the company had an EPS of $0.38, an increase over its 2024 EPS of $0.27.
EPS history for Hester Biosciences Limited from 2006 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $1.78 | 368.18% |
| 2025 | $0.38 | 41.92% |
| 2024 | $0.27 | -30.11% |
| 2023 | $0.38 | -37.44% |
| 2022 | $0.61 | 10.15% |
| 2021 | $0.55 | 21.44% |
| 2020 | $0.46 | -35.30% |
| 2019 | $0.70 | 52.10% |
| 2018 | $0.46 | 8.39% |
| 2017 | $0.43 | 25.27% |
| 2016 | $0.34 | 32.88% |
| 2015 | $0.26 | 38.30% |
| 2014 | $0.19 | -21.61% |
| 2013 | $0.24 | 33.39% |
| 2012 | $0.18 | 0.00% |
| 2011 | 0.00 | -100.00% |
| 2010 | $0.17 | 44.07% |
| 2009 | $0.12 | -46.97% |
| 2008 | $0.23 | 31.80% |
| 2007 | $0.17 | 0.18% |
| 2006 | $0.17 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.03 | 238.93% |
DE
|
|
| $6.01 | 237.69% |
DE
|
|
| $1.53 | -13.84% |
JP
|
|
| $3.66 | 105.72% |
CH
|
|
| $0.45 | -74.71% |
IL
|
Questions about Hester Biosciences Limited's earnings per share (EPS)
What is Hester Biosciences Limited's earnings per share (EPS)?
Hester Biosciences Limited's earnings per share (EPS) over the last twelve months is $1.78, as of Sep 2026.
What was Hester Biosciences Limited's earnings per share (EPS) in 2025?
In 2025, Hester Biosciences Limited's earnings per share (EPS) was $0.38, 40.74% more than in 2024 ($0.27).
How has Hester Biosciences Limited's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Hester Biosciences Limited's earnings per share (EPS) went from $0.46 to $0.38, an average decline of 3.75% a year.
How does Hester Biosciences Limited's earnings per share (EPS) compare with similar companies?
Hester Biosciences Limited's earnings per share (EPS) ($1.78) is higher than that of 2 of the 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.03.